Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 0129: Accelerated vs Standard RT with Cisplatin for Head and Neck Cancer
NCT00047008Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jul 2002
- Primary completion
- Jun 2010
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in head and neck squamous cell carcinoma (HNSCC), sponsored by NRG Oncology. Started Jul 2002; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00047008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047008.